The information described in this paper is preliminary and subject to change. Furthermore, These statements are not guaranteed future performance, and undue reliance should not be placed on them.
Although the world is recovering from the impact of the 2020 pandemic and countries grapple with a slower economy. A steady and robust global growth has been brewing over the years, and that's Cryptocurrency and Blockchain technology.
Mandamus token was founded by Jose R Miranda Ramos and Forex Mandamus Services inc (FXMSINC), Mr. Miranda Ramos, is the CEO of Forex Mandamus Services Inc. FXMSINC team has over 15 years of experience in investing and FXMSINC has been in business since 2015 in New York City in the United States of America.
- Fee Distribution
- Payment for Goods and Donations
- Boost the platform
- other utilities as the platform continue to grow and develop.
In the Mandamus Platform, Members of the crypto community will vote on different projects, and the platform will research and develop the project; after developed and implemented, we will provide a fully open-source report on ways other crypto projects with other coins can integrate it into their blockchain and/or ecosystem.
Projects will enable better integration of Cryptocurrency Transactions into daily life, From tourist locations to the local daily mom and dad store. First Pilot Programs will start in Puerto Rico in Q3 2022 and Other projects voted by the community will start when the price of the Mandamus Coin reaches certain levels to sustain the operations of the voted project.
In order to minimize the price impact of the Mandamus Token, the Mandamus team will not sell tokens to fund the projects but rather will fund projects from revenue from other investments, Membership revenue, revenue from NFT, Youtube revenue, Online, sales, donations, and private investors interested in funding the projects.
A few of the categories where members will vote to research and develop will be Tourism (first project), Medical, Transportation, small business, gaming, Payment in Governmental infrastructure, and other categories that members may vote for in the future.
Because of the operations of Mandamuscoin.org located in the United States of America, The Mandamus Token is not considered a security under the three criteria of the Howey Test, which was developed and named after the Supreme Court case SEC v. W.J. Howey Co., 328 U.S. 293 (1946). and because the Mandamus Token is acts as a replacement for traditional fiat currency is considered a commodity rather than a security.
Ten (10) Percent of All net revenue will be held in a reserve account in the United States of America. Reserve Account will be tied to the Mandamus Coin, and funds will be held in U.S. Dollars, Gold, and short-term U.S. government obligations. The Higher the value of the Mandamus Token and the more transactions made with the token, the higher the number of backed funds in the reserve account.
- On April 22, 2022: Mandamus staff submitted the application for Listing on Coinbase
- On May 15, 2022: Mandamus Token was added to Uniswap
- On May 31, 2022: Mandamus staff submitted the application for Listing on Kraken and TokPie exchange
- On June 3, 2022: Mandamus token was listed on Tokpie
Mandamuscoin.org has allocated a percentage of the Mandamus Token to Airdrop to individuals of the community when the community has met specific achievements within the mandamus ecosystem. For example, when our Social Media Accounts like Instagram, Facebook, Reddit, and Twitter reach a certain amount of organic followers and interactions within the community laid out within the next few weeks, we will airdrop tokens to holders and non-holders of the mandamus token. Another way we will airdrop tokens will be on the lunch of a new project where people will go to a tourist location to claim the airdrop and test our project with local communities in the area.
Part of the generated revenue and growth of the Mandamus token will be used to pay for the treatment of infants with SMA. ZOLGENSMA is a prescription gene therapy used to treat children less than 2 years old with spinal muscular atrophy (SMA). ZOLGENSMA is given as a one-time infusion into a vein. Most of the Infants with SMA type 1 treated with Zolgensma survive after treatment. Zolgensma is one of the most expensive medicine in the world and with our support we can help infants if their insurance doesn't cover the full or partial treatment cost.